[HTML][HTML] A strategy to validate a selection of human effect biomarkers using adverse outcome pathways: proof of concept for phthalates and reproductive effects

KA Baken, N Lambrechts, S Remy, V Mustieles… - Environmental …, 2019 - Elsevier
Human biomonitoring measures the concentrations of environmental chemicals or their
metabolites in body fluids or tissues. Complementing exposure biomarkers with …

A strategy to validate a selection of human effect biomarkers using adverse outcome pathways: Proof of concept for phthalates and reproductive effects

KA Baken, N Lambrechts, S Remy… - Environmental …, 2019 - ui.adsabs.harvard.edu
Human biomonitoring measures the concentrations of environmental chemicals or their
metabolites in body fluids or tissues. Complementing exposure biomarkers with …

A strategy to validate a selection of human effect biomarkers using Adverse Outcome Pathways: proof of concept for phthalates and reproductive effects.

KA Baken, N Lambrechts, S Remy, V Mustieles… - 2019 - cabidigitallibrary.org
Human biomonitoring measures the concentrations of environmental chemicals or their
metabolites in body fluids or tissues. Complementing exposure biomarkers with …

A strategy to validate a selection of human effect biomarkers using adverse outcome pathways: proof of concept for phthalates and reproductive effects

KA Baken, N Lambrechts, S Remy… - Environmental …, 2019 - repository.uantwerpen.be
Human biomonitoring measures the concentrations of environmental chemicals or their
metabolites in body fluids or tissues. Complementing exposure biomarkers with …

A strategy to validate a selection of human effect biomarkers using adverse outcome pathways: Proof of concept for phthalates and reproductive effects

KA Baken, N Lambrechts, S Remy… - Environmental …, 2019 - hero.epa.gov
Human biomonitoring measures the concentrations of environmental chemicals or their
metabolites in body fluids or tissues. Complementing exposure biomarkers with …

A strategy to validate a selection of human effect biomarkers using adverse outcome pathways: Proof of concept for phthalates and reproductive effects

KA Baken, N Lambrechts, S Remy… - Environmental …, 2019 - portal.findresearcher.sdu.dk
Human biomonitoring measures the concentrations of environmental chemicals or their
metabolites in body fluids or tissues. Complementing exposure biomarkers with …

[引用][C] A strategy to validate a selection of human effect biomarkers using adverse outcome pathways: Proof of concept for phthalates and reproductive effects

KA Baken, N Lambrechts, S Remy, V Mustieles… - Environmental …, 2019 - cir.nii.ac.jp
A strategy to validate a selection of human effect biomarkers using adverse outcome pathways:
Proof of concept for phthalates and reproductive effects | CiNii Research CiNii 国立情報学 …

[PDF][PDF] A strategy to validate a selection of human effect biomarkers using adverse outcome pathways: Proof of concept for phthalates and reproductive effects

KA Baken, N Lambrechts, S Remy… - Environmental …, 2019 - researchgate.net
Human biomonitoring measures the concentrations of environmental chemicals or their
metabolites in body fluids or tissues. Complementing exposure biomarkers with …

A strategy to validate a selection of human effect biomarkers using adverse outcome pathways: Proof of concept for phthalates and reproductive effects

KA Baken, N Lambrechts, S Remy… - Environmental …, 2019 - pubmed.ncbi.nlm.nih.gov
Human biomonitoring measures the concentrations of environmental chemicals or their
metabolites in body fluids or tissues. Complementing exposure biomarkers with …

A strategy to validate a selection of human effect biomarkers using adverse outcome pathways: Proof of concept for phthalates and reproductive effects

KA Baken, V Mustieles Miralles, A Rodríguez Carrillo… - 2019 - digibug.ugr.es
Human biomonitoring measures the concentrations of environmental chemicals or their
metabolites in body fluids or tissues. Complementing exposure biomarkers with …